Next-generation point of care diagnostics company
LumiraDx has raised €13M across 1 funding round from 1 investor, most recently a Grant round in Dec 2022. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-12-16 | Grant | €13M |
| Bill & Melinda Gates Foundation Trust |
| View deal → |
